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Disease progression in contralateral carotid artery
is common after endarterectomy
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Objective: Although the North American Symptomatic Carotid Endarterectomy Trial (NASCET) and the Asymptomatic
Carotid Atherosclerosis Study (ACAS) have helped to define the role of carotid endarterectomy (CEA) for both
symptomatic and asymptomatic lesions, the role of surveillance of the contralateral carotid artery remains unclear. The
purpose of this study was to determine the progression of contralateral carotid artery disease with serial duplex
ultrasound scans after CEA compared with the recurrent stenosis rate for the carotid artery ipsilateral to the CEA.
Methods: From January 1990 to December 2000, 473 CEA procedures were performed at a Veterans Affairs Medical
Center. From this group we identified 279 patients who had undergone first-time CEA, as well as preoperative duplex
scanning and postoperative duplex scanning at least once, in the vascular laboratory. At each visit stenosis of the internal
carotid artery (ICA) was categorized as none (0%-14%), mild (15%-49%), moderate (50%-79%), severe (80%-99%), or
occluded. Analysis of probability of freedom from progression was determined. Progression was defined as an increase in
ICA stenosis 50% or greater or increase to a higher category of stenosis if baseline was 50% or greater. The Cox
proportional hazards model was used for data analysis.
Results: Mean patient age was 65.7 years (range, 33-100 years). The 1024 carotid duplex ultrasound scanning
examinations performed (mean, 3.7; range, 2-13) included the last study done before the index CEA and all studies done
after the CEA. Mean follow-up was 27 months (range, 1-137 months). Forty-six patients were found to have
contralateral carotid occlusion at initial duplex scanning, and were therefore excluded from the contralateral progression
analysis. Contralateral progression was more frequent than ipsilateral recurrent stenosis at long-term follow-up (P <
.01). Annual rates of “any progression” and “progression to severe stenosis or occlusion” were 8.3% and 4.4%,
respectively, for contralateral arteries, and 4.3% and 2.4%, respectively for ipsilateral arteries. As a result of surveillance,
43 contralateral CEAs (19% of initial cohort) were performed. Carotid stenosis regressed in 25 arteries (10.7%). Baseline
clinical and demographic factors did not predict disease progression. Baseline contralateral stenosis did not predict time
to “any progression,” but was a strong predictor of “progression to severe stenosis or occlusion” (P < .001).
Conclusions: After CEA, we identified an 8.3% annual rate of progression of contralateral carotid artery stenosis and a
4.4% annual rate of progression to severe stenosis or occlusion. Baseline contralateral stenosis was significantly predictive
of progression to severe stenosis or occlusion. Clinical and demographic factors were not helpful in predicting which
patients would have disease progression. These data may help in assessing the cost effectiveness of duplex scanning
surveillance after CEA. (J Vasc Surg 2004;39:52-7.)
Management of both symptomatic (North American
Symptomatic Carotid Endarterectomy Trial [NASCET]1)
and asymptomatic (Asymptomatic Carotid Atheroschlero-
sis Study [ACAS]2) carotid artery stenosis has been guided
by use of prospective, randomized clinical trials that have
demonstrated the benefit of carotid endarterectomy (CEA)
in patients with high-grade lesions. However, there are
fewer data regarding the natural history and management
of the contralateral, asymptomatic carotid artery. While
there are well-documented studies of carotid plaque pro-
gression in patients who have not undergone surgery,3,4
the frequency with which contralateral carotid artery dis-
ease progresses to clinically significant disease has not been
well-studied. Duplex ultrasound scanning, which has sup-
planted angiography in the preoperative evaluation of ca-
rotid artery stenosis, enables serial evaluation of the con-
tralateral carotid artery to identify occult disease
progression and also affords the opportunity to noninva-
sively correlate the degree of stenosis with neurologic
events.3 The accuracy of duplex ultrasound scanning in
evaluating carotid artery disease has been reported as hav-
ing sensitivity of 99% and specificity of 84%.5,6
We sought to review the natural history of disease
progression in the contralateral carotid artery in patients
who underwent CEA and were surveilled with duplex
ultrasound scanning; imaging of both carotid arteries was
performed at each visit. This allowed us to study both
disease progression in the contralateral carotid artery and
recurrent stenosis in the ipsilateral carotid artery.
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METHODS
The study protocol was reviewed and approved by the
Institutional Review Board of the Pittsburgh Veterans Af-
fairs Medical Center. We identified 473 patients without a
history of CEA who underwent unilateral CEA at the
Pittsburgh Veterans Administration Hospital between Jan-
uary 1990 and December 2000. A subset of 279 patients
underwent preoperative duplex ultrasound scanning and
postoperative ultrasound scanning at least once at the pe-
ripheral vascular laboratory at our facility. Patients with
contralateral carotid artery occlusion demonstrated on the
initial duplex scan were excluded from analysis of contralat-
eral disease progression.
Preoperative duplex scanning was performed in pa-
tients considered for CEA, with the contralateral artery
being routinely imaged. At each visit to the vascular labo-
ratory a registered nurse obtained a detailed neurologic
history and “yes/no” responses to questions about smok-
ing, hyperlipidemia, diabetes, angina, and myocardial in-
farction. An initial postoperative study was obtained 6
months after surgery, and yearly thereafter. More frequent
studies were obtained in patients whose routine studies
revealed evidence of disease progression or who had neu-
rologic symptoms. Patients were considered to have asymp-
tomatic disease if they had no transient ischemic attacks,
amaurosis fugax, or stroke in the 6 months before the
preoperative study. For the last 6 to 7 years we have had a
policy of offering CEA to all patients at good surgical risk
with asymptomatic severe stenosis. Some patients with
documented or developing severe contraleral stenosis did
not undergo CEA because of patient refusal or poor surgi-
cal risk. In patients who underwent contralateral CEA, we
included only duplex scan data obtained before contralat-
eral CEA. All duplex scanning was performed by a regis-
tered vascular technologist in a fully accredited vascular
laboratory, and reviewed by a vascular surgeon. Only tech-
nically adequate studies were included in the dataset. A 128
XP ultrasound machine (Acuson, Mountain View, Calif)
and 5 and 7.5 MHz transducers were used. A standard
protocol was used for assessing the common carotid artery
(CCA), internal carotid artery (ICA), and external carotid
artery. Vertebral artery flow was characterized as antegrade
or retrograde, and plaque anatomy was described in terms
of calcification, echogenicity, and surface quality (eg, irreg-
ular or smooth).
The degree of ICA stenosis was determined on the basis
of velocity criteria and ICA-CCA ratio previously validated
at our institution by means of comparison with contrast-
enhanced angiography. With angiography as the gold stan-
dard, duplex ultrasound scanning was found to have sensi-
tivity and specificity ranging from 70% to 99%, and
excellent correlation in identifying stenosis ( statistic,
.85).7 At each visit stenosis of the ICA was categorized as
none (0%-14%), mild (15%-49%), moderate (50%-79%),
severe (80%-99%), or occluded. The relationship between
ICA-CCA peak systolic velocity (PSV) ratio and corre-
sponding degree of stenosis is shown in Table I.
To quantitate disease progression, we defined “any
progression” as increase in ICA stenosis to 50% or greater
when baseline stenosis was less than 50%, or increase to a
higher degree of stenosis if baseline stenosis was 50% or
greater. Therefore a transition from “none” to “mild”
stenosis was not considered disease progression; all other
increases in degree of stenosis were considered progression.
For some analyses we examined “progression to severe
stenosis or occlusion.” For patients who already had severe
stenosis, this event was considered to have occurred if the
carotid artery became occluded. In our determination of
progression of stenosis of the ipsilateral carotid artery, we
verified that carotid stenosis was reduced to “none” or
“mild” with performance of the index CEA.
The Cox proportional hazards model was used for data
analysis. Kaplan-Meier method plots were constructed to
describe the probability of progression-free survival for
ipsilateral and contralateral carotid arteries. Statistical sig-
nificance was inferred at P .05. Kaplan-Meier curves were
graphed to the time point at which SEM was 10% of survival
function.
RESULTS
Of the 473 patients who underwent CEA, 279 patients
(274 men, 4 women) underwent preoperative and postop-
erative duplex scanning. These patients had a mean age of
66 years (range, 33-100 years). Patient baseline demo-
graphic and clinical characteristics are shown in Table II.
Baseline demographic and clinical characteristics were typ-
ical for patients followed up in major vascular laboratories,
with the exception of the predominance of male patients in
Table I. Velocity criteria
ICA/CCA PSV (cm/s) Inferred degree of stenosis
0.1–1.4 None
1.5–1.9 Mild (15%–49%)
2.0–3.9 Moderate (50%–79%)
4.0 with ICA PSV 125 Severe (80%–99%)
0 (no flow in ICA) Occlusion
ICA, Internal carotid artery; CCA, common carotid artery; PSV, peak
systolic velocity.
Table II. Demographic and clinical features
Baseline patient characteristics (N  279)
Age (y) 65.7
Sex (% male) 98.6
History
Angina (%) 29
Myocardial infarction (%) 35
Current smoking (%) 41
Any smoking (%) 90
Diabetes (%) 34
Hypertension (%) 61
Baseline distribution of internal carotid artery stenosis (n  233)
None/mild (%) 73.4
Moderate (%) 14.3
Severe (%) 12.3
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the Veterans Affairs Medical Center setting. Table II also
shows the distribution of degree of initial stenosis of the
contralateral carotid artery. Forty-six patients had baseline
contralateral carotid artery occlusion; thus the study popu-
lation included 233 patients. Nearly three fourths of pa-
tients had baseline contralateral stenosis less than 50%
(Table II). A total of 1024 duplex ultrasound scanning
examinations were performed (per patient: mean, 3.7;
range, 2-13), including the last study done before the index
CEA and all studies done after CEA. Mean follow-up was
27 months (range, 1-137 months). All duplex ultrasound
scans were technically satisfactory for determination of
ICA-CCA PSV ratio.
The time-dependent risk for progression was analyzed
with the Kaplan-Meier method and the Cox proportional
hazards model. Analysis of the probability of freedom from
“any progression” and “progression to severe stenosis or
occlusion” in both the carotid artery that underwent the
index CEA (ipsilateral) and the contralateral carotid artery
is provided in Figure 1. Contralateral progression exceeded
the rate of ipsilateral recurrent stenosis during long-term
follow-up (P  .01). Moreover, ipsilateral progression
appeared to stabilize at roughly 3 years, in contrast to
continued contralateral progression at up to 6 years of
follow-up. Average annual rates of “any progression” and
“progression to severe stenosis or occlusion” are shown in
Table III. The annual rate of disease progression in the
ipsilateral carotid artery was 4.3%, and the annual rate of
progression to clinically significant stenosis (ie, severe ste-
nosis or occlusion) was 2.4%. The annual rate of disease
progression in the contralateral carotid artery was 8.3%, and
the annual rate of progression to clinically significant ste-
nosis was 4.4%. During follow-up 43 patients (19%) under-
went contralateral CEA, because of either progression of
contralateral carotid disease to severe or increasing PSV in
patients who initially had severe disease. Of these 43 pa-
tients, 13 (30%) had symptoms attributable to carotid
disease; 30 patients (70%) had no symptoms. The initial
degree of carotid stenosis in these patients and the degree
of stenosis before contralateral CEA are shown in Table IV.
While three fourths of these patients had no or mild carotid
stenosis at the initial carotid duplex scanning examination,
Fig 1. Kaplan-Meier method curves show probability of being free from progression as a function of time. Raw
numbers of patients analyzed in each subset at each time point are included below the figure; these were patients “at
risk” for recurrent stenosis or disease progression. Analysis was continued only to a time point at which SEM was 10%
of survival function.
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37% had moderate stenosis and 63% had severe stenosis at
the last duplex scanning examination before CEA. Regres-
sion to a lower degree of carotid stenosis in both ipsilateral
and contralateral carotid arteries was observed in 25 arteries
(10.7%).
We used a Cox univariate proportional hazards model
to analyze the predictive value of 17 variables available at
the baseline study (Table V). None of these variables were
predictive of either ipsilateral or contralateral disease pro-
gression. We found also that baseline contralateral stenosis
did not predict time to “any progression.” However, this
parameter did predict time to “progression to severe steno-
sis or occlusion” (P .001). Kaplan-Meier curves showing
the probability of freedom from progression to severe
stenosis or occlusion as a function of baseline contralateral
stenosis are shown in Figure 2.
DISCUSSION
Several early studies that examined progression of con-
tralateral carotid artery disease after ipsilateral CEA were
performed before publication of randomized clinical trials
such as ACAS and the Veterans Affairs Cooperative Study
Group,8 which suggested a benefit from CEA over medical
treatment in patients with asymptomatic carotid artery
stenosis. These early studies9-11 suggested operative man-
agement only in patients with symptomatic carotid disease.
ACAS showed that for patients without symptoms with
stenosis greater than 60% the aggregate risk reduction over
5 years for ipsilateral stroke and any perioperative stroke or
death was 53% with surgery versus medical therapy. These
data lend support to the concept of using carotid duplex
scanning surveillance, either as a one-time study or serially,
to identify severe or progressive asymptomatic stenosis.
However, it is not clear whether duplex surveillance is
cost-effective. It is highly unlikely that surveillance is cost-
effective for the entire population, but it may be useful
under certain conditions in specific patient groups.12-15
One subset in which serial duplex scanning surveillance
may be of value is the group of patients who have under-
gone unilateral CEA. These patients may reasonably be
expected to be at increased risk for stenosis on the opposite
side. However, previous studies of the value of serial duplex
scanning after unilateral CEA have reached conflicting con-
clusions.16-19
In this study, we did not have access to reliable data
regarding patient symptoms during follow-up after CEA.
However, other studies indicate that disease progression
does not consistently correlate with development of symp-
toms. Roederer et al3 reported that, while disease progres-
sion to clinically relevant stenosis was associated with symp-
toms on the appropriate side in 18% of contralateral carotid
arteries, symptoms developed in 8% of patients without
evidence of progression on duplex ultrasound scans. Simi-
larly, Norrving et al20 compared arteries not operated on in
which disease progressed with those without progression,
and found the proportion of symptom-related sides to be
18% and 4%, respectively. We had no access to data con-
cerning use of antihypertensive medications in our patients.
Unless contraindicated, most of our patients were given
maintenance aspirin therapy. Use of lipid-lowering agents
was implemented at the Veterans Affairs Medical Center in
the mid-1990s, which makes it difficult to draw conclusions
for the study population, inasmuch as the study encom-
passed the time from 1990 through 2000. Nonetheless,
data regarding the natural history of carotid artery disease
progression and threshold for surgical intervention are
important in this era of aggressive medical therapy for
Table III. Annual rates of ipsilateral and contralateral
disease progression
Artery
Any
progression
(%/y)
Progression to
severe
stenosis/occlusion
(%/y)
Ipsilateral carotid 4.3 2.4
Contralateral carotid
Any 8.3 4.4
Baseline
None 3.2
Mild 13.3
Moderate 5.8
Table IV. Progression of contralateral carotid artery
stenosis from initial duplex seen to before
contralateral CEA
None Mild Moderate Severe
Initial 14 18 11 0
Final 0 0 16 27
Only the 43 patients who underwent contralateral CEA are included in this
analysis.
CEA, Carotid endarterectomy.
Table V. Results of Cox proportional hazards model
Demographic variables
Age (y) NS
Sex (male) NS
Clinical variables
Angina NS
Blood pressure
Systolic 160 mm Hg NS
Diastolic 90 mm Hg NS
Diabetes NS
Hypertension NS
Smoking status
current smoker NS
previous smoker NS
Myocardial infarction NS
Amaurosis fugax NS
Vertigo episodes NS
Syncopal episodes NS
Headaches NS
Hemiplegia NS
All variables are dichotomous except age, which was analyzed as a continu-
ous variable.
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cardiovascular risk factors, which includes use of anti-plate-
let and lipid-lowering agents.
In this study, the annual rate of ipsilateral recurrent
stenosis was 4.3%, and the annual rate of progression to
clinically significant recurrent stenosis (ie, severe or oc-
cluded) was 2.4%. This is consistent with published re-
ports.21-23 Further, annual rate of disease progression in
the contralateral carotid artery was 8.3%, and annual rate of
progression to clinically significant stenosis was 4.4%. Nine-
teen percent of this cohort subsequently underwent CEA.
Further evaluation of the 43 patients who underwent con-
tralateral CEA revealed that 70% of these patients had no
symptoms and underwent CEA on the basis of increasing
carotid stenosis. This finding supports the role of duplex
scanning surveillance after CEA, given that three fourths of
these patients had either no or mild stenosis at initial duplex
scanning. At CEA, all patients had either moderate or
severe stenosis.
Baseline stenosis was a strong predictor of time to
“progression to severe stenosis or occlusion.” Of interest,
degree of baseline stenosis did not predict time to “any
progression” in the contralateral carotid artery. These data
indicate that disease progression per se occurs independent
of baseline stenosis. However, patients with more advanced
disease at baseline are more likely to have clinically signifi-
cant stenosis over any given period of observation. These
results are similar to those reported by others.16,24 We
could not identify any clinical risk factors associated with
contralateral disease progression; therefore clinical criteria
cannot be used to identify subgroups at high risk for
progression. Nearly three fourths of patients had baseline
contralateral stenosis less than 50%, indicating that our
results are not skewed by a preponderance of advanced
contralateral disease at the outset. Of note, the male pre-
ponderance in our patient population makes it difficult to
extrapolate our results to female patients.
Our data suggest that contralateral disease progression
is relatively common. If it is assumed that the patient is
considered a candidate for CEA because of asymptomatic
severe stenosis, the goal of duplex scanning surveillance is
to identify development of severe stenosis. We believe that
patients can be adequately monitored with duplex scanning
according to the degree of initial contralateral stenosis. For
stenosis less than 50%, annual or even biennial duplex
ultrasound scanning is adequate. For stenosis greater than
50%, the high frequency of progression to severe stenosis or
occlusion warrants surveillance every 6 months once the
early postoperative study has ruled out technical complica-
tions or early recurrent stenosis of the ipsilateral carotid
artery.
Our data do not enable us to make any definitive
comments about the cost-effectiveness of the strategy de-
scribed. However, a recent decision-analysis study12 con-
cluded that the cost-effectiveness ratio of serial duplex
ultrasound scanning was acceptable in a population of
patients with a rate of progression to severe stenosis of 6%
per year. Our overall cohort had a 4.4% annual rate of
progression to contralateral severe stenosis or occlusion.
This rate was substantially higher, and exceeded the 6%
threshold among patients with baseline stenosis greater
than 50% (Fig 2). In this subset of our cohort, duplex
ultrasound scanning surveillance would appear to be cost-
effective.
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DISCUSSION
Dr George Louridas (Winnipeg, Canada). Did you have a
look at patients’ risk factors? Were they adequately controlled?
Were the cholesterol levels normal? Were there ACE inhibitors?
And what effect does that have on disease progression?
Dr Kathleen G. Raman. That’s an excellent question.
In terms of medications, we really had data as far as whether
antihypertensives were implemented. In the VA population, dur-
ing that study period, aspirin and things like that are pretty much
standard treatment.
The implementation of lipid-lowering agents, however, prob-
ably occurred halfway through, and it’s difficult to say what effect
that would have had, although I think it’s an important criterion to
evaluate in future studies.
Dr Daniel B. Walsh (Lebanon, NH). How many of these
patients became symptomatic? What are your criteria for operation
on the contralateral side? If these men are all 80 years old, likely the
follow-up won’t be of particular utility.
Dr Raman. Those are excellent questions.
In terms of whether the patients were symptomatic, as part of
routine, we offer carotid endarterectomy to patients who are
deemed good surgical risks with above 80% stenosis. Advanced age
may in some cases cause us to observe the patients, but we focus
more on physiologic age than on chronologic age. I should note
that the average age of our patients in this study was in the
mid-60s. We had relatively few patients over age 80.
I think the importance of looking at clinical symptoms is
especially important in the intermediate group, where they may
not necessarily warrant carotid endarterectomy, though if they
have symptoms they get an endarterectomy.
Those data were not complete in our set, so it’s difficult for me
to say anything as far as whether or not symptoms occurred in the
intermediate-risk groups.
With regard to follow-up in elderly patients, I think carotid
stenting might be a viable option in patients at an advanced age or
in poor surgical risk candidates.
Dr Christian Bianchi (Loma Linda, Calif). Any data on
regression of disease in those prospective follow-up patients?
Dr Raman. We have data describing whether regression oc-
curred, though we have not subdivided it by category.
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